At a glance
- Originator GlaxoSmithKline
- Class Antiretrovirals; Lactones; Small molecules
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 06 Jun 2001 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 23 Jan 2001 SmithKline Beecham has merged with Glaxo Wellcome to form GlaxoSmithKline
- 30 Aug 1995 New profile